logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Fujirebio Acquires Adx Neurosciences And Confirms Its Intentions To Bring Better And Earlier Neurodegenerative Disease Diagnostic Solutions To The Global Diagnostics Industry

Jun 23, 2022•over 3 years ago

Acquiring Company

Fujirebio

Acquired Company

ADx NeuroSciences

GentMobileHealth CareBiotechnology

Description

H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio Holdings, Inc., and ADx NeuroSciences NV today announced the acquisition of ADx NeuroSciences by Fujirebio for 40 million euros. Pending the satisfaction of customary closing conditions, the deal is expected to close in July 2022. ADx NeuroSciences becomes a wholly owned subsidiary of Fujirebio Europe NV.

Company Information

Company

Fujirebio

Location

Gent, East Flanders, Belgium

About

Fujirebio is a global leader in the field of in vitro diagnostics (IVD) testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variety of disease states.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed